MicroPort NeuroScientific (HKSE:02172) Tax Expense: HK$51.9 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02172 MicroPort NeuroScientific Corp HKSE:02172
93 GF Score
Price HK$9.01
GF Value HK$13.19
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is MicroPort NeuroScientific Tax Expense?

MicroPort NeuroScientific HKSE:02172 -1.37% 93 Tax Expense is HK$51.9 Mil as of Dec. 2025. GuruFocus rates HKSE:02172 with a GF Score™ of 93/100 and a GF Value™ of HK$13.19 (Possible Value Trap). The stock has 3 warning signs investors should review.

MicroPort NeuroScientific's tax expense for the months ended in Dec. 2025 was HK$29.2 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2025 was HK$51.9 Mil.


MicroPort NeuroScientific  (HKSE:02172) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


MicroPort NeuroScientific Tax Expense Related Terms


MicroPort NeuroScientific Tax Expense Historical Data

* Premium members only.

The historical data trend for MicroPort NeuroScientific's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroPort NeuroScientific Tax Expense Chart

MicroPort NeuroScientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Expense
Get a 7-Day Free Trial 9.47 22.73 30.05 57.52 52.18

MicroPort NeuroScientific Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.76 33.23 24.56 22.77 29.16
HKSE:02172
93GF Score
MicroPort NeuroScientific Corp HKSE:02172
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MicroPort NeuroScientific Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$51.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of HK$51.9 Mil mean?
MicroPort NeuroScientific (HKSE:02172) has a Tax Expense of HK$51.9 Mil as of Dec. 2025. Tax expense is the amount of tax the company pays in an accounting period. View historical data on MicroPort NeuroScientific and its competitors.
Is MicroPort NeuroScientific's Tax Expense too high?
MicroPort NeuroScientific's current Tax Expense is HK$51.9 Mil. Overall, MicroPort NeuroScientific has a GF Score™ of 93/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroPort NeuroScientific's Tax Expense compare to ABT and SYK?
MicroPort NeuroScientific's Tax Expense of HK$51.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Medical Devices & Instruments company?
A good Tax Expense depends on the Medical Devices & Instruments industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on MicroPort NeuroScientific and its competitors. MicroPort NeuroScientific's current Tax Expense is HK$51.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort NeuroScientific stock overvalued right now?
Based on GuruFocus' analysis, MicroPort NeuroScientific (HKSE:02172) is currently considered Possible Value Trap. The stock's GF Value™ is HK$13.19, compared to a current price of HK$9.01 — trading 31.7% below its estimated fair value. The current Tax Expense is HK$51.9 Mil. MicroPort NeuroScientific's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For MicroPort NeuroScientific (HKSE:02172), the current Tax Expense is HK$51.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MicroPort NeuroScientific (HKSE:02172) Overvalued in 2026?

Based on GuruFocus' analysis, MicroPort NeuroScientific stock appears to be undervalued. The current stock price of HK$9.01 is trading 31.7% below its estimated GF Value™ of HK$13.19. GuruFocus considers MicroPort NeuroScientific to be Possible Value Trap.

Key valuation signals for HKSE:02172:

  • Tax Expense: HK$51.9 Mil
  • GF Value™: HK$13.19 vs. price of HK$9.01 (31.7% below fair value)
  • GF Score™: 93/100 with 3 warning signs

No single metric tells the full story. See the HKSE:02172 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MicroPort NeuroScientific Business Description

Address No. 1661 Zhangdong Road, Zhangjiang High-tech Park, Pudong New Area, Shanghai, CHN
MicroPort NeuroScientific Corp is in the neuro-interventional medical device industry, dedicated to providing solutions for physicians and patients. The company boasts a comprehensive portfolio of approved therapeutic products covering all of three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke. The company generates almost all of its revenue from the sale of medical devices. Geographically, the company generates the majority of its revenue from the PRC region, and also has operations in Israel.
93GF Score

Get the complete analysis for HKSE:02172

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$9.01
Price
HK$13.19
GF Value